Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Anxiolytic Drugs: Overview01:26

Anxiolytic Drugs: Overview

465
Anxiolytic drugs are vital in managing anxiety disorders by effectively alleviating symptoms such as excessive fear, tachycardia, and tremors. There are several classes of anxiolytic medications, each with unique mechanisms of action and potential side effects.
Primary Types of Anxiolytic Drugs
1. Benzodiazepines:
Benzodiazepines bind to the GABA-A receptor in the brain, enhancing GABA's interaction. This action reduces neurotransmission, effectively blocking anxiety-associated limbic...
465

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Comment on: Comparing Michigan Neuropathy Screening Instrument Scores with Plantar Sensory Nerve Conduction Studies in Diabetic Neuropathy.

Journal of the College of Physicians and Surgeons--Pakistan : JCPSP·2026
Same author

Proteomic Signatures of Adiposomes Track Cardiometabolic Risk Reduction Following Bariatric Surgery.

International journal of molecular sciences·2026
Same author

The learning curve of thulium laser enucleation of the prostate: a single-centre experience.

Archivio italiano di urologia, andrologia : organo ufficiale [di] Societa italiana di ecografia urologica e nefrologica·2026
Same author

Early vs. delayed primary local therapy and survival in de novo metastatic prostate cancer: target trial emulation.

World journal of urology·2026
Same author

Endothelial and cardiac dysfunction in long COVID With cardiovascular symptoms is associated with imbalance in the ADMA-DDAH-NOx pathway.

Frontiers in cardiovascular medicine·2026
Same author

Dual Antiplatelet Therapy and Arteriovenous Malformations Increase 30-Day Readmission Rates for Patients Who Undergo Endoscopic Procedures for Gastrointestinal Bleeding.

Journal of clinical gastroenterology·2026

Related Experiment Video

Updated: Sep 3, 2025

Testing Animal Anxiety in Rats: Effects of Open Arm Ledges and Closed Arm Wall Transparency in Elevated Plus Maze Test
07:54

Testing Animal Anxiety in Rats: Effects of Open Arm Ledges and Closed Arm Wall Transparency in Elevated Plus Maze Test

Published on: June 29, 2018

13.7K

Taurine-Derived Compounds Produce Anxiolytic Effects in Rats Following Developmental Lead Exposure.

Lorenz S Neuwirth1,2, Bright U Emenike3, George B Cruz4,5

  • 1Department of Psychology, SUNY Old Westbury, Old Westbury, NY, USA. neuwirthl@oldwestbury.edu.

Advances in Experimental Medicine and Biology
|July 26, 2022
PubMed
Summary
This summary is machine-generated.

Taurine derivatives show promise in mitigating anxiety-like behaviors caused by developmental lead exposure. These compounds, particularly TD-101 and TD-103 in females, offer potential therapeutic strategies targeting the GABAergic system for neurodevelopmental disorders.

Keywords:
Anxiety-like behaviorsAnxiolytic drugsDevelopmental lead (Pb2+) exposureGABAergic systemLead poisoningTaurine derivatives

More Related Videos

Moderate Prenatal Alcohol Exposure and Quantification of Social Behavior in Adult Rats
11:01

Moderate Prenatal Alcohol Exposure and Quantification of Social Behavior in Adult Rats

Published on: December 14, 2014

9.8K
Elevated Plus Maze Test Combined with Video Tracking Software to Investigate the Anxiolytic Effect of Exogenous Ketogenic Supplements
05:42

Elevated Plus Maze Test Combined with Video Tracking Software to Investigate the Anxiolytic Effect of Exogenous Ketogenic Supplements

Published on: January 7, 2019

31.5K

Related Experiment Videos

Last Updated: Sep 3, 2025

Testing Animal Anxiety in Rats: Effects of Open Arm Ledges and Closed Arm Wall Transparency in Elevated Plus Maze Test
07:54

Testing Animal Anxiety in Rats: Effects of Open Arm Ledges and Closed Arm Wall Transparency in Elevated Plus Maze Test

Published on: June 29, 2018

13.7K
Moderate Prenatal Alcohol Exposure and Quantification of Social Behavior in Adult Rats
11:01

Moderate Prenatal Alcohol Exposure and Quantification of Social Behavior in Adult Rats

Published on: December 14, 2014

9.8K
Elevated Plus Maze Test Combined with Video Tracking Software to Investigate the Anxiolytic Effect of Exogenous Ketogenic Supplements
05:42

Elevated Plus Maze Test Combined with Video Tracking Software to Investigate the Anxiolytic Effect of Exogenous Ketogenic Supplements

Published on: January 7, 2019

31.5K

Area of Science:

  • Neuroscience
  • Toxicology
  • Pharmacology

Background:

  • Developmental lead (Pb2+) exposure is a neurotoxicant that disrupts brain excitation-inhibition balance via the GABA-shift.
  • Taurine, a neuroprotective agent, regulates brain excitability and can enhance neuronal inhibition through GABA-A receptors (GABA-AR).
  • Understanding taurine's role in mitigating lead-induced neurotoxicity and anxiety is crucial for developing effective treatments.

Purpose of the Study:

  • To investigate the anxiolytic potential of taurine derivatives in rats with developmental lead exposure.
  • To assess the efficacy of taurine and its derivatives in alleviating anxiety-like behaviors and restoring GABAergic function.
  • To explore sex-specific responses to taurine-based treatments in lead-exposed rats.

Main Methods:

  • Developmental exposure groups: Control (0 ppm) and perinatal lead acetate (150 or 1,000 ppm).
  • Behavioral testing (postnatal days 36-45): Open Field (OF) test for locomotor activity and Elevated Plus Maze (EPM) for anxiety-like behaviors.
  • Drug administration: Intraperitoneal injections of saline, taurine, or taurine derivatives (TD-101, TD-102, TD-103) prior to EPM testing under triple-blind conditions.

Main Results:

  • Lead exposure increased locomotor activity in both male and female rats compared to controls.
  • Control females exhibited higher anxiety-like behaviors than control males in the EPM.
  • Lead-exposed rats showed selective responses to TD drugs, with TD-101 effective in males, and TD-101 and TD-103 showing greater anxiolytic effects in females.

Conclusions:

  • Taurine and its derivatives demonstrate potential as pharmacotherapies for anxiety associated with developmental lead exposure.
  • The study highlights sex-specific mechanisms and GABAergic actions of taurine derivatives in alleviating neurodevelopmental toxicity.
  • Further research into these compounds could lead to novel treatments for lead-induced behavioral alterations.